Jens Christian Jensenius

RECOMBINANT HUMAN MANNAN-BINDING LECTIN

Research output: Patent

The present invention relates to methods of producing and/or isolating MEL compositions. In particular the inven­tion relates to methods of producing and/or isolating novel recombinant human MEL preparations with high similarity to natural human MEL. The MEL preparations may be used in compositions, medicaments and in methods for treatment of conditions such as those related to immunosuppressive conditions and/or to conditions of MEL deficiencies includ­ing latent conditions. Conditions of deficiencies of Mannan­Binding Lectin (MEL) are associated with increased sus­ceptibility to infections.
Original languageEnglish
Patent numberUS 6,846,649 Bl
CountryDenmark
Priority date14/05/1999
Publication statusPublished - 25 Jan 2005

See relations at Aarhus University Citationformats

ID: 153443234